Hochschulschrift
Targeting the NO-cGMP-PKG signalling pathway protects the heart against ischemia-reperfusion injury
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
40 cm
- Extent
-
98 Bl.
- Language
-
Englisch
- Notes
-
Ill., graph. Darst.
Heidelberg, Univ., Diss., 2013
- Classification
-
Medizin, Gesundheit
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 11:42 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Taurine protects kidney from ischemia, reperfusion injury after transplantation
Role of NO-cGMP signalling pathway in mediation of ischemia-reperfusion lung injury
Deficiency of myostatin protects skeletal muscle cells from ischemia reperfusion injury
The serine protease activated protein C protects against renal ischemia reperfusion injura
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on NK Cells Protects From Hepatic Ischemia-Reperfusion Injury
Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury
Platelets in myocardial ischemia/reperfusion injury
Mitochondrial involvement in ischemia-reperfusion injury
Platelet contributions to myocardial ischemia/reperfusion injury
Mesenchymal stem cell-derived conditioned medium protects vascular grafts of brain-dead rats against in vitro ischemia, reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Taurine protects kidney from ischemia, reperfusion injury after transplantation
Role of NO-cGMP signalling pathway in mediation of ischemia-reperfusion lung injury
Deficiency of myostatin protects skeletal muscle cells from ischemia reperfusion injury
The serine protease activated protein C protects against renal ischemia reperfusion injura
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on NK Cells Protects From Hepatic Ischemia-Reperfusion Injury
Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury
Platelets in myocardial ischemia/reperfusion injury
Mitochondrial involvement in ischemia-reperfusion injury
Platelet contributions to myocardial ischemia/reperfusion injury
Mesenchymal stem cell-derived conditioned medium protects vascular grafts of brain-dead rats against in vitro ischemia, reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Taurine protects kidney from ischemia, reperfusion injury after transplantation
Role of NO-cGMP signalling pathway in mediation of ischemia-reperfusion lung injury
Deficiency of myostatin protects skeletal muscle cells from ischemia reperfusion injury
The serine protease activated protein C protects against renal ischemia reperfusion injura
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on NK Cells Protects From Hepatic Ischemia-Reperfusion Injury
Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury
Platelets in myocardial ischemia/reperfusion injury
Mitochondrial involvement in ischemia-reperfusion injury
Platelet contributions to myocardial ischemia/reperfusion injury